Issue 19, May 14, 2012

Vol. 4, Issue: 19, 5/14/12

Welcome to Science Clips, CDC's weekly digest!

This week, Science Clips features scientific articles related to this month's Public Health Grand Rounds on the growing threat of multidrug-resistant gonorrhea, and what actions public health, clinicians, and at-risk people can take now. For more information on Grand Rounds, please see https://www.cdc.gov/Features/GrandRounds. Science Clips will return to its regular format next week.

The Science Clips is in the public domain and may be freely forwarded and reproduced without permission. The original sources and the CDC Science Clips should be cited as sources. Articles featured in Science Clips may be in-press or uncorrected proofs.

For assistance in obtaining copies of these articles, contact the library at cdclibrary@cdc.gov or 404-639-1717. Please note that links below to CDC licensed materials are available only through the Intranet and may go through the SFX server. From the SFX window, just click on the full-text link to reach the full-text.

 

1. Key Scientific Articles in Featured Topic Areas

   • Communicable Diseases - Multidrug Resistant Gonorrhea

     1. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone
        Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, et al.
        Antimicrob Agents Chemother. 2011 Jul;55(7):3538-45.
        
     2. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure
        Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P.
        Antimicrob Agents Chemother. 2012 Mar;56(3):1273-80.
        
     3. Antimicrobial resistance in sexually transmitted infections in the developed world: implications for rational treatment
        Ison CA.
        Curr Opin Infect Dis. 2012 Feb;25(1):73-8.
        
     4. Phenotypic and genotypic properties of Neisseria gonorrhoeae isolates in Norway in 2009: antimicrobial resistance warrants an immediate change in national management guidelines
        Hjelmevoll SO, Golparian D, Dedi L, Skutlaberg DH, Haarr E, Christensen A, Jorgensen S, et al.
        Eur J Clin Microbiol Infect Dis. 2011 Sep 30.
        
     5. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011
        Unemo M, Golparian D, Stary A, Eigentler A.
        Euro Surveill. 2011 ;16(43).
        
     6. Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management
        Ison CA, Alexander S.
        Expert Rev Anti Infect Ther. 2011 Oct;9(10):867-76.
        
     7. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales
        Chisholm SA, Alexander S, Desouza-Thomas L, Maclure-Webster E, Anderson J, Nichols T, Lowndes CM, et al.
        J Antimicrob Chemother. 2011 Nov;66(11):2509-12.
        
     8. Surveillance of gonococcal antimicrobial susceptibility resulting in early detection of emerging resistance
        Lo JY, Ho KM, Lo AC.
        J Antimicrob Chemother. 2012 Feb 14.
        
     9. Impact of fluoroquinolone resistance mutations on gonococcal fitness and in vivo selection for compensatory mutations
        Kunz AN, Begum AA, Wu H, D'Ambrozio JA, Robinson JM, Shafer WM, Bash MC, et al.
        J Infect Dis. 2012 May 3.
        
     10. A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae
         Ohneck EA, Zalucki YM, Johnson PJ, Dhulipala V, Golparian D, Unemo M, Jerse AE, et al.
         MBio. 2011 ;2(5).
         
     11. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010
         Martin I, Sawatzky P, Allen V, Hoang L, Lefebvre B, Mina N, Wong T, et al.
         Sex Transm Dis. 2012 Apr;39(4):316-23.
         
     12. Antibiotic-resistant phenotypes and genotypes of Neisseria gonorrhoeae isolates in Japan: identification of strain clusters with multidrug-resistant phenotypes
         Tanaka M, Koga Y, Nakayama H, Kanayama A, Kobayashi I, Saika T, Iyoda T.
         Sex Transm Dis. 2011 Sep;38(9):871-5.
         
   
   

2. CDC Authored Publications

   
   The names of CDC authors are indicated in bold text.

   • Chronic Diseases and Conditions

     13. Obesity and severe obesity forecasts through 2030
         Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, Dietz W.
         Am J Prev Med. 2012 .
         
     14. New roles for public health in cancer screening
         Plescia M, Richardson LC, Joseph D.
         CA Cancer J Clin. 2012 May 9.
         
     15. Toward standardizing and reporting colorectal cancer screening indicators on an international level: the International Colorectal Cancer Screening Network
         Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, Villain P.
         Int J Cancer. 2012 Jun 15;130(12):2961-2973.
         
     16. Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder
         Hornig M, Briese T, Licinio J, Khabbaz RF, Altshuler LL, Potkin SG, Schwemmle M, Siemetzki U, Mintz J, Honkavuori K, Kraemer HC, Egan MF, Whybrow PC, Bunney WE, Lipkin WI.
         Mol Psychiatry. 2012 May;17(5):486-93.
         
     17. Kawasaki syndrome and factors associated with coronary artery abnormalities, California
         Callinan LS, Tabnak F, Holman RC, Maddox RA, Kim JJ, Schonberger LB, Vugia DJ, Belay ED.
         Pediatr Infect Dis J. 2012 May 4.
         

   • Communicable Diseases

     18. B lymphocyte-derived humoral immune defenses in breast milk transmission of the HIV-1
         Belec L, Kourtis AP.
         Adv Exp Med Biol. 2012 ;743:139-60.
         
     19. Breastfeeding and transmission of HIV-1: epidemiology and global magnitude
         Fowler MG, Kourtis AP, Aizire J, Onyango-Makumbi C, Bulterys M.
         Adv Exp Med Biol. 2012 ;743:3-25.
         
     20. HIV-1 and breastfeeding in the United States
         Little KM, Hu DJ, Dominguez KL.
         Adv Exp Med Biol. 2012 ;743:261-70.
         
     21. Cellular immunity in breast milk: implications for postnatal transmission of HIV-1 to the infant
         Sabbaj S, Ibegbu CC, Kourtis AP.
         Adv Exp Med Biol. 2012 ;743:161-9.
         
     22. HIV-1 virological response and prevalence of HIV-1 drug resistance among patients receiving antiretroviral therapy, Shandong, China
         Zhang J, Kang D, Lin B, Sun X, Fu J, Bi Z, Nkengasong JN, Yang C.
         AIDS Res Hum Retroviruses. 2012 May 8.
         
     23. Moving toward TB elimination: implementation of statewide targeted tuberculin testing in Tennessee
         Cain KP, Garman KN, Laserson KF, Ferrousier-Davis OP, Miranda AG, Wells CD, Haley CA.
         Am J Respir Crit Care Med. 2012 May 3.
         
     24. Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009
         Larson E, O'Bra H, Brown J, Mbengashe T, Klausner JD.
         BMC Public Health. 2012 ;12:173.
         
     25. HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries
         Bennett DE, Jordan MR, Bertagnolio S, Hong SY, Ravasi G, McMahon JH, Saadani A, Kelley KF.
         Clin Infect Dis. 2012 May;54 Suppl 4:S280-9.
         
     26. Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria
         Ugbena R, Aberle-Grasse J, Diallo K, Bassey O, Jelpe T, Rottinghaus E, Azeez A, Akpan R, Muhammad M, Shanmugam V, Singh S, Yang C.
         Clin Infect Dis. 2012 May;54 Suppl 4:S375-80.
         
     27. Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RD(Rio)Mycobacterium tuberculosis sublineage
         Weisenberg SA, Gibson AL, Huard RC, Kurepina N, Bang H, Lazzarini LC, Chiu Y, Li J, Ahuja S, Driscoll J, Kreiswirth BN, Ho JL.
         Infect Genet Evol. 2012 Jun;12(4):664-70.
         
     28. Socio-demographic differences in opinions about 2009 pandemic influenza A (H1N1) and seasonal influenza vaccination and disease among adults during the 2009-2010 influenza season
         Santibanez TA, Singleton JA, Santibanez SS, Wortley P, Bell BP.
         Influenza Other Respi Viruses. 2012 May 9.
         
     29. Haemophilus haemolyticus causing clinical disease
         Anderson R, Wang X, Briere EC, Katz LS, Cohn AC, Clark TA, Messonnier NE, Mayer LW.
         J Clin Microbiol. 2012 May 9.
         
     30. Understanding influenza virus resistance to antiviral agents; early warning signs for wider community circulation
         Fry AM, Gubareva LV.
         J Infect Dis. 2012 May 4.
         
     31. Noroviruses: the perfect human pathogens?
         Hall AJ.
         J Infect Dis. 2012 Jun;205(11):1622-4.
         
     32. HIV-HBV coinfection--a global challenge
         Kourtis AP, Bulterys M, Hu DJ, Jamieson DJ.
         N Engl J Med. 2012 May 10;366(19):1749-52.
         

   • Disaster Control and Emergency Services

     33. Investigations of selected historically important syndromic outbreaks: impact and lessons learned for public health preparedness and response
         Goodman RA, Posid JM, Popovic T.
         Am J Public Health. 2012 Jun;102(6):1079-90.
         

   • Disease Reservoirs and Vectors

     34. Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection
         Crabtree MB, Kent Crockett RJ, Bird BH, Nichol ST, Erickson BR, Biggerstaff BJ, Horiuchi K, Miller BR.
         PLoS Negl Trop Dis. 2012 May;6(5):e1639.
         

   • Drug Safety

     35. Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers
         Dooley KE, Bliven-Sizemore EE, Weiner M, Lu Y, Nuermberger EL, Hubbard WC, Fuchs EJ, Melia MT, Burman WJ, Dorman SE.
         Clin Pharmacol Ther. 2012 Apr 4.
         

   • Epidemiology and Surveillance

     36. Surveillance of transmitted HIV drug resistance using matched plasma and dried blood spot specimens from voluntary counseling and testing sites in Ho Chi Minh City, Vietnam, 2007-2008
         Duc NB, Hien BT, Wagar N, Tram TH, Giang le T, Yang C, Wolfe MI, Hien NT, Tuan NA.
         Clin Infect Dis. 2012 May;54 Suppl 4:S343-7.
         
     37. Public health surveillance and data collection: general principles and impact on hemophilia care
         Soucie JM.
         Hematology. 2012 Apr;17 Suppl 1:144-6.
         
     38. Evaluation of integrated registers for tuberculosis and HIV surveillance in children, Ethiopia, 2007-2009
         Click ES, Feleke B, Pevzner E, Fantu R, Gadisa T, Assefa D, Melaku Z, Cain K, Menzies H.
         Int J Tuberc Lung Dis. 2012 May;16(5):625-7.
         
     39. Molecular epidemiological investigation to determine the source of a fatal case of serotype 22F pneumococcal meningitis
         Lamaro-Cardoso J, de Lemos AP, Carvalho Mda G, Pimenta FC, Roundtree A, Motta L, Vieira MA, Sgambatti S, Thorn LK, Pessoa-Junior V, Minamisava R, Harrison LH, Beall BW, Brandileone MC, Andrade AL.
         J Med Microbiol. 2012 May;61(Pt 5):686-92.
         
     40. A systematic review of rotavirus strain diversity in India, Bangladesh, and Pakistan
         Miles MG, Lewis KD, Kang G, Parashar UD, Steele AD.
         Vaccine. 2012 Apr 27;30 Suppl 1:A131-9.
         

   • Genetics and Genomics

     41. Knowledge integration at the center of genomic medicine
         Khoury MJ, Gwinn M, Dotson WD, Schully SD.
         Genet Med. 2012 May 3.
         

   • Health Behavior and Risk

     42. Homophobia is associated with sexual behavior that increases risk of acquiring and transmitting HIV infection among black men who have sex with men
         Jeffries WL, Marks G, Lauby J, Murrill CS, Millett GA.
         AIDS Behav. 2012 May 9.
         
     43. Modifiable risk factors for West Nile virus infection during an outbreak--Arizona, 2010
         Gibney KB, Colborn J, Baty S, Bunko Patterson AM, Sylvester T, Briggs G, Stewart T, Levy C, Komatsu K, Macmillan K, Delorey MJ, Mutebi JP, Fischer M, Staples JE.
         Am J Trop Med Hyg. 2012 May;86(5):895-901.
         
     44. Healthy lifestyle behaviors and all-cause mortality among adults in the United States
         Ford ES, Bergmann MM, Boeing H, Li C, Capewell S.
         Prev Med. 2012 Apr 29.
         

   • Health Communication and Education

     45. Water treatment and handwashing behaviors among non-pregnant friends and relatives of participants in an antenatal hygiene promotion program in Malawi
         Russo ET, Sheth A, Menon M, Wannemuehler K, Weinger M, Kudzala AC, Tauzie B, Masuku HD, Msowoya TE, Quick R.
         Am J Trop Med Hyg. 2012 May;86(5):860-5.
         
     46. Effects of the Gama Cuulu radio serial drama on HIV-related behavior change in Zambia
         Kraft JM, Hill Z, Membe I, Zhang Y, Meassick EO, Monsour M, Maumbi M, Ndubani P, Manengu JM, Mwinga A.
         J Health Commun. 2012 May 8.
         

   • Immunity and Immunization

     47. Neonatal vaccine-strain varicella zoster virus infection 22 days after maternal post-partum vaccination
         Kluthe M, Herrera A, Blanca H, Leung J, Bialek SR, Schmid DS.
         Pediatr Infect Dis J. 2012 May 8.
         
     48. Middle school vaccination requirements and adolescent vaccination coverage
         Bugenske E, Stokley S, Kennedy A, Dorell C.
         Pediatrics. 2012 May 7.
         
     49. Effectiveness and cost of immunization recall at school-based health centers
         Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, Daley MF, Dickinson LM.
         Pediatrics. 2012 May 7.
         
     50. Effectiveness and net cost of reminder/recall for adolescent immunizations
         Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A.
         Pediatrics. 2012 May 7.
         
     51. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children
         Anh DD, Van Trang N, Thiem VD, Anh NT, Mao ND, Wang Y, Jiang B, Hien ND, Luan LT.
         Vaccine. 2012 27 Apr;30 Suppl 1:A114-A121.
         
     52. Immunogenicity of the pentavalent rotavirus vaccine in African infants
         Armah GE, Breiman RF, Tapia MD, Dallas MJ, Neuzil KM, Binka FN, Sow SO, Ojwando J, Ciarlet M, Steele AD.
         Vaccine. 2012 Apr 27;30 Suppl 1:A86-93.
         
     53. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030
         Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.
         Vaccine. 2012 Apr 27;30 Suppl 1:A7-A14.
         
     54. Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs
         Banyai K, Laszlo B, Duque J, Steele AD, Nelson EA, Gentsch JR, Parashar UD.
         Vaccine. 2012 Apr 27;30 Suppl 1:A122-30.
         
     55. Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data
         Gershman MD, Staples JE, Bentsi-Enchill AD, Breugelmans JG, Brito GS, Bastoscamacho LA, Cottin P, Domingo C, Durbin A, Gascon J, Guenaneche F, Hayes EB, Jelenik Z, Khromava A, Martins RD, Wilson MM, Massy N, Nasidi A, Niedrig M, Sherwat A, Tsai T, Vilella A, Wilson ME, Kohl KS.
         Vaccine. 2012 May 3.
         
     56. Parental and societal values for the risks and benefits of childhood combination vaccines
         Gidengil C, Lieu TA, Payne K, Rusinak D, Messonnier M, Prosser LA.
         Vaccine. 2012 May 14;30(23):3445-52.
         
     57. Rotavirus vaccines for children in developing countries: understanding the science, maximizing the impact, and sustaining the effort
         Neuzil KM, Parashar UD, Steele AD.
         Vaccine. 2012 Apr 27;30 Suppl 1:A1-2.
         
     58. Workshop on intussusception in African countries - meeting report
         Steele AD, Patel M, Cunliffe NA, Bresee JS, Borgstein E, Parashar UD.
         Vaccine. 2012 Apr 27;30 Suppl 1:A185-9.
         
     59. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa
         Tapia MD, Armah G, Breiman RF, Dallas MJ, Lewis KD, Sow SO, Rivers SB, Levine MM, Laserson KF, Feikin DR, Victor JC, Ciarlet M, Neuzil KM, Steele AD.
         Vaccine. 2012 Apr 27;30 Suppl 1:A79-85.
         

   • Injury and Violence

     60. Community violence exposure and adolescent substance use: does monitoring and positive parenting moderate risk in urban communities?
         Lee R.
         J Community Psychol. 2012 May;40(4):406-421.
         
     61. Prevalence of traumatic brain injury among prisoners in South Carolina
         Ferguson PL, Pickelsimer EE, Corrigan JD, Bogner JA, Wald M.
         J Head Trauma Rehabil. 2012 May;27(3):E11-20.
         
     62. Helmet use among motorcyclists in Cambodia: a survey of use, knowledge, attitudes, and practices
         Bachani AM, Tran NT, Sann S, Ballesteros MF, Gnim C, Ou A, Sem P, Nie X, Hyder AA.
         Traffic Inj Prev. 2012 ;13 Suppl 1:31-6.
         

   • Laboratory Sciences

     63. Investigation of aerosol surface area estimation from number and mass concentration measurements: particle density effect
         Ku BK, Evans DE.
         Aerosol Sci Tech. 2012 ;46(4):473-484.
         
     64. Quartz measurement in coal dust with high-flow rate samplers: laboratory study
         Lee T, Lee EG, Kim SW, Chisholm WP, Kashon M, Harper M.
         Ann Occup Hyg. 2012 ;56(4):413-425.
         
     65. A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model
         Thibodeaux BA, Garbino NC, Liss NM, Piper J, Schlesinger JJ, Blair CD, Roehrig JT.
         Antiviral Res. 2012 Apr;94(1):1-8.
         
     66. Suppression of interferon-alpha signaling by hepatitis E virus
         Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J, Kamili S.
         Hepatology. 2012 May;55(5):1324-32.
         
     67. Mycobacterium tuberculosis spoligotypes that may derive from mixed strain infections are revealed by a novel computational approach
         Lazzarini LC, Rosenfeld J, Huard RC, Hill V, Lapa ES, Desalle R, Rastogi N, Ho JL.
         Infect Genet Evol. 2012 Jun;12(4):798-806.
         
     68. TB-lineage: an online tool for classification and analysis of strains of Mycobacterium tuberculosis complex
         Shabbeer A, Cowan LS, Ozcaglar C, Rastogi N, Vandenberg SL, Yener B, Bennett KP.
         Infect Genet Evol. 2012 Jun;12(4):789-97.
         
     69. T cell receptors are structures capable of initiating signaling in the absence of large conformational rearrangements
         Fernandes RA, Shore DA, Vuong MT, Yu C, Zhu X, Pereira-Lopes S, Brouwer H, Fennelly JA, Jessup CM, Evans EJ, Wilson IA, Davis SJ.
         J Biol Chem. 2012 Apr 13;287(16):13324-35.
         
     70. Evaluation of mycobacterial interspersed repetitive-unit-variable-number tandem-repeat genotyping as performed in laboratories in Canada, France, and the United States
         Cowan LS, Hooks DP, Christianson S, Sharma MK, Alexander DC, Guthrie JL, Jamieson FB, Supply P, Allix-Beguec C, Cruz L, Desmond E, Kramer R, Lugo S, Rudrik J.
         J Clin Microbiol. 2012 May;50(5):1830-1.
         
     71. Prediction system for rapid identification of salmonella serotypes based on pulsed-field gel electrophoresis fingerprints
         Zou W, Lin WJ, Hise KB, Chen HC, Keys C, Chen JJ.
         J Clin Microbiol. 2012 May;50(5):1524-32.
         
     72. Temporal differences in blood meal detection from the midguts of Triatoma infestans
         Pinto J, Roellig DM, Gilman RH, Calderon M, Bartra C, Salazar R, Bern C, Ancca-Juarez J, Levy M, Naquira C, Cama V.
         Rev Inst Med Trop Sao Paulo. 2012 Apr;54(2):83-8.
         
     73. Characterization of Neisseria meningitidis isolates from Egypt using multilocus sequence typing
         Klena JD, Wasfy MO, Nada RA, Ahmed SF, Maksoud MA, Marfin A, Pimentel G.
         Trans R Soc Trop Med Hyg. 2012 May;106(5):309-14.
         
     74. Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso
         Kristiansen PA, Ouedraogo AS, Sanou I, Ky Ba A, Ouedraogo CD, Sangare L, Ouedraogo R, Kandolo D, Diomande F, Kabore P, Hassan-King M, Thomas JD, Hatcher CP, Andreasson I, Clark TA, Preziosi MP, Laforce M, Caugant DA.
         Trans R Soc Trop Med Hyg. 2012 May;106(5):289-97.
         

   • Maternal and Child Health

     75. Risk of bottle-feeding for rapid weight gain during the first year of life
         Li R, Magadia J, Fein SB, Grummer-Strawn LM.
         Arch Pediatr Adolesc Med. 2012 May;166(5):431-6.
         
     76. Outpatient tonsillectomy in children: demographic and geographic variation in the United States, 2006
         Boss EF, Marsteller JA, Simon AE.
         J Pediatr. 2012 May;160(5):814-9.
         
     77. Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000-2011
         Okoroh EM, Azonobi IC, Grosse SD, Grant AM, Atrash HK, James AH.
         J Womens Health (Larchmt). 2012 May 3.
         

   • Occupational Safety and Health

     78. Comparison of work-related symptoms and visual contrast sensitivity between employees at a severely water-damaged school and a school without significant water damage
         Thomas G, Burton NC, Mueller C, Page E, Vesper S.
         Am J Ind Med. 2012 May 7.
         
     79. Motivating ergonomic computer workstation setup: sometimes training is not enough
         Sigurdsson SO, Artnak M, Needham M, Wirth O, Silverman K.
         Int J Occup Saf Ergon. 2012 ;18(1):27-33.
         

   • Physical Activity

     80. Cardiorespiratory fitness and proximity to commercial physical activity facilities among 12th grade girls
         Dowda M, Pfeiffer KA, Lobelo F, Porter DE, Pate RR.
         J Adolesc Health. 2012 May;50(5):497-502.
         

   • Public Health Leadership and Management

     81. Implementation of school policies to prevent youth tobacco use in Alabama
         Geiger BF, Vaid I, Beeson D, Riddle B.
         J Sch Health. 2012 Jun;82(6):277-284.
         

   • Reproductive Health

     82. Racial and ethnic disparities in preconception risk factors and preconception care
         Denny CH, Floyd RL, Green PP, Hayes DK.
         J Womens Health (Larchmt). 2012 May 4.
         
   
   

3. Public Health Articles Noted in the Media

   • MMWR in the Media

     83. Sunburn and sun protective behaviors among adults aged 18-29 years - United States, 2000-2010
         MMWR Morb Mortal Wkly Rep. 2012 May 11;61(18):317-22.
         
     84. Use of indoor tanning devices by adults - United States, 2010
         MMWR Morb Mortal Wkly Rep. 2012 May 11;61(18):323-6.
         

   • Chronic Diseases and Conditions

     85. Obesity and severe obesity forecasts through 2030
         Finkelstein EA, Khavjou OA, Thompson H, Trogdon JG, Pan L, Sherry B, Dietz W.
         Am J Prev Med. 2012 .
         
     86. Hospitalization for stroke in U.S. hospitals, 1989-2009
         Hall MJ, Levant S, DeFrances CJ.
         NCHS data brief. 2012 May(95):1-8.
         

   • Health Disparities

     87. Contribution of screening and survival differences to racial disparities in colorectal cancer rates
         Lansdorp-Vogelaar I, Kuntz KM, Knudsen AB, van Ballegooijen M, Zauber AG, Jemal A.
         Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):728-36.
         

   • Immunity and Immunization

     88. Middle school vaccination requirements and adolescent vaccination coverage
         Bugenske E, Stokley S, Kennedy A, Dorell C.
         Pediatrics. 2012 May 7.
         
     89. Effectiveness and cost of immunization recall at school-based health centers
         Kempe A, Barrow J, Stokley S, Saville A, Glazner JE, Suh C, Federico S, Abrams L, Seewald L, Beaty B, Daley MF, Dickinson LM.
         Pediatrics. 2012 May 7.
         
     90. Effectiveness and net cost of reminder/recall for adolescent immunizations
         Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, Dong F, Beaty B, Dickinson LM, Kempe A.
         Pediatrics. 2012 May 7.
         

   • Vital Statistics

     91. Infant mortality statistics from the 2008 period linked birth/infant death data set
         Mathews TJ, MacDorman MF.
         Natl Vital Stat Rep. 2012 ;60(5):1-49.
         
   
   

Back to Top

____

DISCLAIMER: Articles listed in the CDC Science Clips are selected by the Stephen B. Thacker CDC Library to provide current awareness of the public health literature. An article's inclusion does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.